Immunotherapy for Sars-Cov-2: Potential Opportunities

Tehran University of Medical Sciences

Science Communicator Platform

Share By

Immunotherapy for Sars-Cov-2: Potential Opportunities Publisher Pubmed

Pashaei M¹ ; Rezaei N^{1, 2, 3}

Source: Expert Opinion on Biological Therapy Published:2020

Abstract

[No abstract available]

Style	Citing Format
MLA	Pashaei M, Rezaei N. "Immunotherapy for Sars-Cov-2: Potential Opportunities." Expert Opinion on Biological Therapy, vol. 20, no. 10, 2020, pp. 1111-1116.
APA	Pashaei M, Rezaei N (2020). Immunotherapy for Sars-Cov-2: Potential Opportunities. Expert Opinion on Biological Therapy, 20(10), 1111-1116.
Chicago	Pashaei M, Rezaei N. "Immunotherapy for Sars-Cov-2: Potential Opportunities." Expert Opinion on Biological Therapy 20, no. 10 (2020): 1111-1116.
Harvard	Pashaei M, Rezaei N (2020) 'Immunotherapy for Sars-Cov-2: Potential Opportunities', Expert Opinion on Biological Therapy, 20(10), pp. 1111-1116.
Vancouver	Pashaei M, Rezaei N. Immunotherapy for Sars-Cov-2: Potential Opportunities. Expert Opinion on Biological Therapy. 2020;20(10):1111-1116.
BibTex	@article{ author = {Pashaei M and Rezaei N}, title = {Immunotherapy for Sars-Cov-2: Potential Opportunities}, journal = {Expert Opinion on Biological Therapy}, volume = {20}, number = {10}, pages = {1111-1116}, year = {2020} }
RIS	TY - JOUR AU - Pashaei M AU - Rezaei N TI - Immunotherapy for Sars-Cov-2: Potential Opportunities JO - Expert Opinion on Biological Therapy VL - 20 IS - 10 SP - 1111 EP - 1116 PY - 2020 ER -